Selected article for: "cross validation and International license"
Author: Jessica A. Plante; Kenneth S. Plante; Lisa E. Gralinski; Anne Beall; Martin T. Ferris; Daniel Bottomly; Richard Green; Shannon K. McWeeney; Mark T. Heise; Ralph S. Baric; Vineet D. Menachery
Title: Mucin 4 Protects Female Mice from Coronavirus Pathogenesis
  • Document date: 2020_2_20
    • ID: 99sbhbuo_22
    Snippet: Because Muc4 modulated SARS-CoV susceptibility independent of viral replication, a 146 cross-platform validation study was undertaken to begin assessing whether the Muc4 had 147 widespread importance in viral pathogenesis. Chinkungunya virus (CHIKV), an alphavirus, 148 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.....
    Document: Because Muc4 modulated SARS-CoV susceptibility independent of viral replication, a 146 cross-platform validation study was undertaken to begin assessing whether the Muc4 had 147 widespread importance in viral pathogenesis. Chinkungunya virus (CHIKV), an alphavirus, 148 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.19.957118 doi: bioRxiv preprint causes inflammatory arthritis and swelling within the joints in human patients. Importantly, 149

    Search related documents:
    Co phrase search for related documents
    • human patient and SARS CoV susceptibility: 1
    • human patient and validation study: 1
    • human patient and viral pathogenesis: 1
    • human patient and viral replication: 1, 2, 3, 4
    • inflammatory arthritis and validation study: 1, 2
    • inflammatory arthritis and widespread importance: 1
    • SARS CoV susceptibility and validation study: 1, 2
    • SARS CoV susceptibility and viral pathogenesis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • SARS CoV susceptibility and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • validation study and viral pathogenesis: 1, 2
    • validation study and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9